109 - Protecting Patients at All Costs, Being a CQO in Big Pharma, Supply Chain Security and Generic Drugs with Martin Van Trieste

Let's Combinate · 8 Nov 2023 · 42m

What this episode covers

Martin Van Trieste, former CQO at Amgen and CEO of Civica Rx, discusses the critical importance of supply chain security and quality leadership in pharmaceutical manufacturing. He details the creation of RX-360 following the heparin contamination crisis and explains how Civica Rx addresses drug shortages by restructuring business models to make essential generic drugs economically viable for manufacturers. Van Trieste argues that systemic design, rather than just compliance, is key to preventing human error and ensuring patient safety across the industry.

Other shows on the same ground, closest first.

  • OnTrack · 45m

    Supply Chain Challenges in Medical Device Manufacturing

    Supply chain executive Simon Hinds discusses the unique complexities of medical device and life sciences supply chains, contrasting them with automotive and consumer electronics. He explains how regulatory barriers, traceability requirements like CFR 21 Part 11, and mutual recognition agreements impact sourcing and manufacturing strategies. Hinds details the challenges of scaling from prototype to volume, managing tier 1-3 supplier risks, and navigating geopolitical tariffs through diversification and postponement strategies.

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

  • How I Built This · 34m

    HIBT Lab! Mark Cuban Cost Plus Drug Company: Mark Cuban

    Serial entrepreneur Mark Cuban discusses his newest venture, the Mark Cuban Cost Plus Drug Company (MCCPDC), which he co-founded with radiologist Alex Oshmiansky to disrupt the pharmaceutical industry by offering generic drugs at transparent, low costs. Cuban explains how he educated himself on the complex drug pricing ecosystem, identifying Pharmacy Benefit Managers (PBMs) and vertically integrated insurance companies as the primary drivers of inflated prices rather than manufacturing costs. He details the company's business model as a public benefit corporation that charges a flat 15% markup plus handling and shipping fees, bypassing traditional insurance rebates to undercut standard co-pays. Cuban also touches on his interest in NFTs, his strategy for staying grounded through social media feedback, and his belief that wealthy individuals have a responsibility to fund solutions for systemic problems like high drug prices.

  • Global Medical Device Podcast · 37m

    #390: Building a Non-BS QMS: 4 Core Principles for MedTech Success with Ashkon Rasooli

    Ashkon Rasooli, a quality and regulatory expert, joins host Etienne Nichols to outline four core principles for building an effective, non-burdensome Quality Management System (QMS) for medical device companies. Rasooli argues for 'Quality over Proceduralism,' 'Culture over Mandate,' 'Redundancy over Duplication,' and 'Conciseness over Verbosity' to ensure the QMS serves the business rather than just acting as a compliance checkbox. He advises new founders to engage quality and regulatory advisors early in the design phase to optimize architecture and avoid costly retrospective documentation. The discussion also covers the strategic decision of whether to treat quality as a minimum regulatory hurdle or a key business differentiator.

  • Global Medical Device Podcast · 50m

    #352: Fundamentals of Quality & Regulatory

    Jennifer Mascioli-Tudor, CEO of JMT Compliance Consulting and former quality leader at Medtronic, Boston Scientific, and Johnson & Johnson, discusses the strategic role of quality and regulatory professionals in the medical device industry. She emphasizes that effective quality management requires strong project management skills, proactive stakeholder influence, and a deep understanding of human factors to prevent post-market failures. Mascioli-Tudor also advocates for building a culture of psychological safety and continuous improvement, arguing that quality teams must act as business partners rather than just compliance police.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.